IDiyas

For the Inventor, By the Inventor

Cambridge, MA, United States of America

David Sabatini

USPTO Granted Patents = 25

Average Co-Inventor Count = 2.8

ph-index = 8

Forward Citations = 254(Granted Patents)


Company Filing History:

goldMedal25 out of 303 
 
Whitehead Institute for Biomedical Research
 patents
silverMedal4 out of 8,369 
 
Massachusetts Institute of Technology
 patents
bronzeMedal3 out of 1,206 
 
Dana-farber-cancer Institute Inc.
 patents
4. 1 out of 118 
 
Howard Hughes Medical Institute
 patents
5. 1 out of 443 
 
The Broad Institute, Inc.
 patents
6. 1 out of 3,435 
 
National Institutes of Health, a Component of the US Dept. of Health & Human Services
 patents
7. 1 out of 2,961 
 
Harvard College
 patents
where one patent can have more than one assignee

Years Active: 2003-2023

Loading Chart...
25 patents (USPTO):Explore Patents
1. 11571441 - Sideroflexins as mitochondrial serine transporters (2023-02-07),
2. 11499981 - Methods of identifying modulators of SAMTOR-GATOR1 interaction and use of same to modulate mTORC1 (2022-11-15),
3. 11453858 - Human plasma-like medium (2022-09-27),
4. 11326209 - Cell-based genomic recorded accumulative memory (2022-05-10),
5. 11225469 - Inhibitors of phosphoglycerate dehydrogenase (PHGDH) and uses thereof (2022-01-18),
6. 11149267 - Functional genomics using CRISPR-Cas systems, compositions, methods, screens and applications thereof (2021-10-19),
7. 11092608 - Methods of identifying modulators of CASTOR1-GATOR2 interaction and use of same to modulate mTORC1 (2021-08-17),
8. 10426757 - Compositions and methods for promoting intestinal stem cell and/or non-stem progenitor cell function (2019-10-01),
9. 10168338 - Methods of identifying modulators of sestrin-gator-2 interaction for modulating mTORC1 activity (2019-01-01),
10. 10126303 - Methods for identifying compounds as modulators of SLC38A9 interactions (2018-11-13),
11. 10123985 - Therapeutic strategies for treating mitochondrial disorders (2018-11-13),
12. 9551036 - Metabolic gene mesenchymal signatures and uses thereof (2017-01-24),
13. 9532997 - Compositions and methods for promoting intestinal stem cell function (2017-01-03),
14. 9493775 - Inhibition of the glycine cleavage system for treatment of cancer (2016-11-15),
15. 8999660 - Methods Relating to Mammalian Rictor Polypeptide (2015-04-07),

Title: The Innovative Journey of David Sabatini

Introduction: David Sabatini, a renowned inventor based in Cambridge, MA (US), has made significant contributions to the field of science and technology through his groundbreaking inventions and research endeavors.

Latest Patents: David Sabatini holds several patents in the areas of biotechnology, genomics, and medical devices, showcasing his continuous commitment to innovation and advancement in these fields.

Career Highlights: With a distinguished career spanning over two decades, David Sabatini has established himself as a leading figure in the scientific community. His work has not only revolutionized the way we approach medical research but has also paved the way for new discoveries and advancements in the field.

Collaborations: Throughout his career, David Sabatini has collaborated with top research institutions, universities, and biotechnology companies to further his research and bring his inventions to life. His collaborative efforts have led to the development of cutting-edge technologies that have the potential to impact the lives of many.

Conclusion: In conclusion, David Sabatini's relentless pursuit of innovation and his passion for pushing the boundaries of science have solidified his position as a visionary inventor. His work continues to inspire and shape the future of biotechnology and medical research, leaving a lasting impact on the industry as a whole.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…